Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc.

NASDAQ:AVIR

Overview | Financials
Company Name Atea Pharmaceuticals, Inc.
Symbol AVIR
Currency USD
Price 3.6
Market Cap 303,919,200
Dividend Yield 0%
52-week-range 2.765 - 4.6
Industry Biotechnology
Sector Healthcare
CEO Dr. Jean-Pierre Sommadossi Ph.D.
Website https://ateapharma.com

An error occurred while fetching data.

About Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752,

Related Stocks

Atai Life Sciences N.V. logo

Atai Life Sciences N.V.

ATAI

1.19 USD

InnovAge Holding Corp. logo

InnovAge Holding Corp.

INNV

6.21 USD

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

ACB

5.41 USD

HealthStream, Inc. logo

HealthStream, Inc.

HSTM

28.34 USD

iTeos Therapeutics, Inc. logo

iTeos Therapeutics, Inc.

ITOS

14.8 USD

ZimVie Inc. logo

ZimVie Inc.

ZIMV

16.07 USD

Avidity Biosciences, Inc. logo

Avidity Biosciences, Inc.

RNA

40.46 USD

Nkarta, Inc. logo

Nkarta, Inc.

NKTX

5.32 USD

Financials

Numbers are in millions USD

Numbers are in millions USD